<?xml version="1.0" encoding="UTF-8"?>
<p>The pathogenicity of coronaviruses is highly correlated with the immune dysregulation and the inflammatory response that is triggered by viral particles in the respiratory tract (
 <xref rid="B16" ref-type="bibr">Channappanavar and Perlman, 2017</xref>; 
 <xref rid="B46" ref-type="bibr">Huang et al., 2020</xref>). Hence, various authors have proposed the therapeutic use of mesenchymal stem cells (MSC) known for their broad immunomodulatory and multipotent differentiating features.
</p>
